GF Fund Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$500K Sell
4,384
-179
-4% -$21.1K 0.01% 216
2026
Q2
$487K Sell
4,563
-43,933
-91% -$5.32M 0.01% 218
2026
Q1
$7.93M Buy
48,496
+6,269
+15% +$964K 0.13% 105
2025
Q4
$7.35M Buy
42,227
+37,679
+828% +$6.88M 0.13% 123
2025
Q3
$655K Sell
4,548
-33
-0.7% -$4.04K 0.01% 214
2025
Q2
$461K Hold
4,581
– – 0.01% 262
2025
Q1
$349K Buy
4,581
+825
+22% +$63.1K 0.01% 284
2024
Q4
$259K Buy
+3,756
New +$271K 0.01% 266

Other funds holding INSM

GF Fund Management's INSM Position: Q3 2026 in Review

GF Fund Management reduced its Insmed (INSM) stake by 3.9% in Q3 2026, selling an estimated $21.1K and leaving 4,384 shares worth $500K. The position accounts for 0.01% of the portfolio, ranked #216.

GF Fund Management first reported a position in INSM in Q4 2024 and has held it in 8 quarters since. The position peaked at $7.93M in Q1 2026. 695 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • GF Fund Management held 4,384 shares of Insmed worth $500K as of Q3 2026.
  • GF Fund Management sold 179 Insmed shares in Q3 2026, an estimated $21.1K.
  • Insmed made up 0.01% of GF Fund Management's portfolio in Q3 2026, its #216 holding.
  • GF Fund Management first reported a position in Insmed in Q4 2024 and has held it in 8 quarters since.
  • GF Fund Management's Insmed position peaked at $7.93M in Q1 2026.
  • 695 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.